Literature DB >> 15382257

Long-term effects of amygdala GABA receptor blockade on specific subpopulations of hippocampal interneurons.

Sabina Berretta1, Nicholas Lange, Sujoy Bhattacharyya, Ronnie Sebro, Jessica Garces, Francine M Benes.   

Abstract

Growing evidence indicates that the amygdala modulates hippocampal functions. To test the hypothesis that this modulation may involve long-lasting effects on interneuronal networks in the hippocampus, changes in the expression of neurochemical markers specific for different interneuronal subpopulations were assessed in adult rats 96 h following acute infusion of low doses of the GABAA receptor antagonist picrotoxin into the amygdala. The numerical density (Nd) of somata showing immunoreactivity (IR) for parvalbumin (PVB) was decreased in dentate gyrus (DG) and the CA4-2 region, while that of calretinin (CR)-IR was decreased in DG and CA2. The Nd of calbindin D28k (CB)-IR somata was decreased in CA3-2. The densities of axon terminals arising from PVB-IR and cholecystokinin (CCK)-IR basket neurons were also altered, with those of CCK-IR terminals increased across all sectors, while PVB-IR terminals were decreased only in the CA region. Increases in CCK-IR terminals were paralleled by increases of terminals with IR for the 65-kD isoform of glutamate decarboxylase (GAD65). Mixed-effects statistical models, adapted specifically for these analyses, indicated that perturbations of amygdalar inputs to the hippocampus significantly alter the drive that hippocampal PVB-, CR-, and CB-IR neurons within the dentate gyrus/CA4 region exercise on CCK-IR terminals within the same region as well as in CA3-1. These results suggest that amygdalar modulation of specific neuronal subpopulations may induce lasting and far-reaching changes in the hippocampus during normal functioning, as well as in diseases involving a disruption of amygdalar activity. In particular, changes in specific interneuronal markers within selective hippocampal sectors detected in the present results are strikingly similar to those reported in this region in schizophrenia. These similarities suggest that, in this disease, a disruption of GABAergic transmission within the amygdala may play a significant role in the induction of abnormalities in the hippocampus. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15382257     DOI: 10.1002/hipo.20002

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  29 in total

Review 1.  Developmental pathology, dopamine, stress and schizophrenia.

Authors:  Daniel J Lodge; Anthony A Grace
Journal:  Int J Dev Neurosci       Date:  2010-08-19       Impact factor: 2.457

2.  Depressive-like behavior in adolescents after maternal separation: sex differences, controllability, and GABA.

Authors:  Melanie P Leussis; Nadja Freund; Heather C Brenhouse; Britta S Thompson; Susan L Andersen
Journal:  Dev Neurosci       Date:  2012-07-06       Impact factor: 2.984

3.  Regulation of synaptic plasticity in a schizophrenia model.

Authors:  Barbara Gisabella; Vadim Y Bolshakov; Francine M Benes
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-30       Impact factor: 11.205

4.  Construction and implantation of a microinfusion system for sustained delivery of neuroactive agents.

Authors:  Miles G Cunningham; Ryan P O'Connor; Sydney E Wong
Journal:  J Vis Exp       Date:  2008-03-17       Impact factor: 1.355

Review 5.  Gamma synchrony: towards a translational biomarker for the treatment-resistant symptoms of schizophrenia.

Authors:  Michael J Gandal; J Christopher Edgar; Kerstin Klook; Steven J Siegel
Journal:  Neuropharmacology       Date:  2011-02-22       Impact factor: 5.250

Review 6.  Stress during critical periods of development and risk for schizophrenia.

Authors:  Felipe V Gomes; Xiyu Zhu; Anthony A Grace
Journal:  Schizophr Res       Date:  2019-01-30       Impact factor: 4.939

7.  Nonsteroidal anti-inflammatory treatment prevents delayed effects of early life stress in rats.

Authors:  Heather C Brenhouse; Susan L Andersen
Journal:  Biol Psychiatry       Date:  2011-06-16       Impact factor: 13.382

8.  Characterization of a Novel Mutation in SLC1A1 Associated with Schizophrenia.

Authors:  Parisa Afshari; Marina Myles-Worsley; Ori S Cohen; Josepha Tiobech; Stephen V Faraone; William Byerley; Frank A Middleton
Journal:  Mol Neuropsychiatry       Date:  2015-07-08

9.  Gestational methylazoxymethanol acetate administration: a developmental disruption model of schizophrenia.

Authors:  Daniel J Lodge; Anthony A Grace
Journal:  Behav Brain Res       Date:  2009-02-02       Impact factor: 3.332

10.  Afferent drive of medial prefrontal cortex by hippocampus and amygdala is altered in MAM-treated rats: evidence for interneuron dysfunction.

Authors:  Behnaz Esmaeili; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2013-03-07       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.